Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MYL9 Antikörper (AA 12-27)

MYL9 Reaktivität: Human, Maus, Ratte, Avian, Säugetier WB, IHC (p), IP, EIA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN303105
  • Target Alle MYL9 Antikörper anzeigen
    MYL9 (Myosin Regulatory Light Chain 2, Smooth Muscle Isoform (MYL9))
    Bindungsspezifität
    • 16
    • 15
    • 11
    • 9
    • 7
    • 6
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 12-27
    Reaktivität
    • 79
    • 36
    • 30
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Maus, Ratte, Avian, Säugetier
    Wirt
    • 83
    • 2
    Kaninchen
    Klonalität
    • 82
    • 3
    Polyklonal
    Konjugat
    • 38
    • 7
    • 6
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Dieser MYL9 Antikörper ist unkonjugiert
    Applikation
    • 73
    • 37
    • 32
    • 26
    • 26
    • 13
    • 12
    • 6
    • 6
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Enzyme Immunoassay (EIA)
    Spezifität
    Amino acids 12-27 of Human Myosin light chain protein.
    Kreuzreaktivität (Details)
    Species reactivity (expected):Avian, Mammal, Mouse and Rat.
    Species reactivity (tested):Human.
    Aufreinigung
    Immunoaffinity Chromatography.
    Immunogen
    Synthetic peptide - KLH conjugated.
    Top Product
    Discover our top product MYL9 Primärantikörper
  • Applikationshinweise
    ELISA (1/5000-1/20000). Western Blot (1/500-1/2000). Immunoprecipitation. Immunohistochemistry on Paraffin Sections (2.5 μg/mL). This antibody was validated for use in immunohistochemistry on a panel of 21formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigenretrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides wereincubated with biotinylated secondary antibody LS-D1, followed by Alkalinephosphatase-streptavidin and chromogen.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    0.71 mg/mL
    Buffer
    0.02 M Potassium Phosphate, 0.12 M Sodium Chloride, pH 7.2 with 0.01 % (w/v) Sodium Azide as preserevative.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
  • Target
    MYL9 (Myosin Regulatory Light Chain 2, Smooth Muscle Isoform (MYL9))
    Andere Bezeichnung
    MYL9 (MYL9 Produkte)
    Synonyme
    LC20 antikoerper, MLC-2C antikoerper, MLC2 antikoerper, MRLC1 antikoerper, MYRL2 antikoerper, AI327049 antikoerper, MLC20 antikoerper, Mylc2c antikoerper, RLC-C antikoerper, myosin antikoerper, regulatory antikoerper, MRCL3 antikoerper, MRLC2 antikoerper, MYL9 antikoerper, zgc:103467 antikoerper, myl9 antikoerper, zgc:77916 antikoerper, myosin light chain 9 antikoerper, myosin, light polypeptide 9, regulatory antikoerper, myosin light chain 9 L homeolog antikoerper, myosin, light chain 9, regulatory antikoerper, myosin, light chain 12A, regulatory, non-sarcomeric antikoerper, myosin, light chain 9a, regulatory antikoerper, myosin, light chain 9b, regulatory antikoerper, MYL9 antikoerper, Myl9 antikoerper, myl9.L antikoerper, MYL12A antikoerper, myl9a antikoerper, myl9b antikoerper
    Hintergrund
    Myosin is the major component of thick muscle filaments, and is a long asymmetric molecule containing a globular head and a long tail. The molecule consists of two heavy chains each ~200,000 daltons, and four light chains each ~16,000 - 21,000 daltons. Activation of smooth and cardiac muscle primarily involves pathways that increase calcium and myosin phosphorylation resulting in contraction. Myosin light chain phosphatase acts to regulate muscle contraction by dephosphorylating activated myosin light chain. The selected peptide sequence used to generate the polyclonal antibody is located near the amino terminal end of the polypeptide corresponding to the smooth/non-muscle form of myosin regulatory light chain found in cardiac myocytes in addition to smooth and non-muscle cells. This sequence differs from that of the sarcomeric/ cardiac form of myosin regulatory light chain that has a different sequence around the phosphorylation site. Human, Mouse and Rat have almost identical sequences.Synonyms: LC20, MLC-2C, MLC2, MRLC1, MYRL2, Myosin RLC, Myosin regulatory light chain 2, Myosin regulatory light chain MRLC1, Myosin regulatory light polypeptide 9, smooth muscle
    Gen-ID
    10398
    NCBI Accession
    NP_006088
    UniProt
    P24844
Kundenservice